Ricevi le ultime notizie sulle azioni EyePoint Pharmaceuticals con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di EYPT

Ultime notizie per

EYEPOINT PHARMACEUTICALS INC

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals Inc

News

Press Releases

EyePoint Announces Participation at Upcoming Investor Conferences

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Health Care

EyePoint Completes Enrollment of Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration

EyePoint to Report Second Quarter 2025 Financial Results on August 6, 2025

Earnings

EyePoint Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Developments

EyePoint to Present at the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference

Markets

EYPT

Amphastar Pharmaceuticals, Inc. - Common Stock

Amphastar Pharma

Aquestive Therapeutics, Inc. - Common Stock

Aquestive Therapeutics

Arvinas

Collegium Pharmaceutical, Inc. - Common Stock

Collegium Pharmaceutical

Cormedix

Cronos Group

Enliven Therapeutics, Inc. - Common Stock

Enliven Therapeutics

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics

GH Research

Innoviva

Maze Therapeutics

MBX Biosciences

Mind Medicine (MindMed) Inc. - Common Shares

Mind Medicine

Nektar Therapeutics

Oculis Holding

Pacira BioSciences

Phathom Pharmaceuticals, Inc. - Common Stock

Phathom Pharmaceuticals

Rapport Therapeutics, Inc. - Common Stock

Rapport Therapeutics

Septerna

SIGA Technologies

SNDL

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Terns Pharmaceuticals, Inc. - Common Stock

Comments

EyePoint Pharmaceuticals Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO